These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
501 related articles for article (PubMed ID: 23578069)
21. Therapeutic challenges for systemic sclerosis: facts and future targets. Cerinic Matucci M; Del Rosso A; Federico P; Livi R; Fiori G; Bartoli F; Blagojevic J; Tempestini A; Pignone A Ann N Y Acad Sci; 2007 Sep; 1110():448-54. PubMed ID: 17911460 [TBL] [Abstract][Full Text] [Related]
22. [Pulmonary hypertension and right ventricular failure. Part XI. Endothelin receptor blockers in the treatment of primary pulmonary arterial hypertension]. Batyraliev TA; Makhmutkhodzhaev SA; Ekinsi E; Pataraia SA; Pershukov IV; Sidorenko BA; Preobrazhenskiĭ DV Kardiologiia; 2007; 47(7):73-82. PubMed ID: 18260899 [TBL] [Abstract][Full Text] [Related]
23. Current treatment options in children with pulmonary arterial hypertension and experiences with oral bosentan. Beghetti M Eur J Clin Invest; 2006 Sep; 36 Suppl 3():16-24. PubMed ID: 16919006 [TBL] [Abstract][Full Text] [Related]
24. [Efficacy of oral sildenafil as rescue therapy in patients with severe pulmonary arterial hypertension chronically treated with prostacyclin. Long-term results]. Jiménez López-Guarch C; Escribano Subias P; Tello de Meneses R; Delgado Jiménez JF; Sadia Pérez D; Velázquez Martín MT; Gómez Sánchez MA; Sáenz de la Calzada C Rev Esp Cardiol; 2004 Oct; 57(10):946-51. PubMed ID: 15469792 [TBL] [Abstract][Full Text] [Related]
26. Tadalafil: a long-acting phosphodiesterase-5 inhibitor for the treatment of pulmonary arterial hypertension. Arif SA; Poon H Clin Ther; 2011 Aug; 33(8):993-1004. PubMed ID: 21762988 [TBL] [Abstract][Full Text] [Related]
27. Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil. Launay D; Sitbon O; Le Pavec J; Savale L; Tchérakian C; Yaïci A; Achouh L; Parent F; Jais X; Simonneau G; Humbert M Rheumatology (Oxford); 2010 Mar; 49(3):490-500. PubMed ID: 20015974 [TBL] [Abstract][Full Text] [Related]
28. Management of dyspnea in advanced pulmonary arterial hypertension. Sajkov D; Petrovsky N; Palange P Curr Opin Support Palliat Care; 2010 Jun; 4(2):76-84. PubMed ID: 20407377 [TBL] [Abstract][Full Text] [Related]
29. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension. Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071 [TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of novel-targeted drugs in the treatment of pulmonary arterial hypertension: a Bayesian network meta-analysis. Fu W; He W; Li Y; Chen Y; Liang J; Lei H; Fu L; Chen Y; Ren N; Jiang Q; Shen Y; Ma R; Wang T; Wang X; Zhang N; Xiao D; Liu C Drug Deliv; 2021 Dec; 28(1):1007-1019. PubMed ID: 34060401 [No Abstract] [Full Text] [Related]
32. Inhaled epoprostenol for the treatment of pulmonary arterial hypertension in critically ill adults. Buckley MS; Feldman JP Pharmacotherapy; 2010 Jul; 30(7):728-40. PubMed ID: 20575636 [TBL] [Abstract][Full Text] [Related]
33. Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial. Coghlan JG; Galiè N; Barberà JA; Frost AE; Ghofrani HA; Hoeper MM; Kuwana M; McLaughlin VV; Peacock AJ; Simonneau G; Vachiéry JL; Blair C; Gillies H; Miller KL; Harris JHN; Langley J; Rubin LJ; Ann Rheum Dis; 2017 Jul; 76(7):1219-1227. PubMed ID: 28039187 [TBL] [Abstract][Full Text] [Related]
34. Prostacyclins in pulmonary arterial hypertension: the need for earlier therapy. Vachiéry JL Adv Ther; 2011 Apr; 28(4):251-69. PubMed ID: 21455725 [TBL] [Abstract][Full Text] [Related]
35. [Current recommendations on diagnosis and treatment of pulmonary arterial hypertension]. Ter Arkh; 2012; 84(4):57-63. PubMed ID: 22774493 [TBL] [Abstract][Full Text] [Related]